Missouri 2026 Regular Session Status: In Committee

SB 1086 — Permits over-the-counter purchase of ivermectin and hydroxychloroquine tablets without a prescription

Last action — Hearing Conducted S Families, Seniors and Health Committee

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced December 01, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 14% · moderate confidence
  • In Committee

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

SB 1086 - Under this act, ivermectin and hydroxychloroquine tablets suitable for human use may be sold or purchased as over-the-counter medications in Missouri without a prescription or consultation with a pharmacist or other health care professional. This act is identical to SB 1275 (2026), substantially similar to SB 1489 (2026), SB 744 (2025), and HB 2581 (2024), and similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), the truly agreed to and finally passed HCS/SS/SCS/SB 878 (2026), and HCS/HB 3009 (2026). SARAH HASKINS

Bill Text

Action History

  1. Hearing Conducted S Families, Seniors and Health Committee

  2. Second Read and Referred S Families, Seniors and Health Committee

  3. S First Read

  4. Prefiled

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 198 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (198)

198 members have not signed on to this bill.

Show all 198 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 1086 do?
SB 1086 - Under this act, ivermectin and hydroxychloroquine tablets suitable for human use may be sold or purchased as over-the-counter medications in Missouri without a prescription or consultation with a pharmacist or other health care professional. This act is identical to SB 1275 (2026), substantially similar to SB 1489 (2026), SB 744 (2025), and HB 2581 (2024), and similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), the truly agreed to and finally passed HCS/SS/SCS/SB 878 (2026), and HCS/HB 3009 (2026). SARAH HASKINS
Who sponsors SB 1086?
SB 1086 is sponsored by Joe Nicola.
What is the current status of SB 1086?
This bill is in committee in the Senate. Introduced December 01, 2025. It must pass committee before a floor vote.
Where can I track SB 1086?
Track SB 1086 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1086

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 1086

Last checked for changes about 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →